Noveris Health Sciences is trading at CA$0.28 (-5.08%), with continued volatility and selling pressure; the specific cause remains unclear.

  • No new company-specific announcement or confirmed catalyst was found for August 14, 2026.
  • Management said on August 6, 2026, that it was unaware of any material operational change explaining unusual market activity.
  • The decline follows losses on August 11–13, while broader markets were broadly stable to slightly higher.